About W8M-MC-LAA2
A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Management with LY3841136 and Tirzepatide, Alone or in Combination, in Adult Participants with Obesity or Overweight with T2D
W8M-MC-LAA2 Screenshots
Tap to Rate: